# Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow

> **NCT02788084** · — · UNKNOWN · sponsor: **Alberta Health Services, Calgary** · enrollment: 80 (estimated)

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02788084
- **Lead sponsor:** Alberta Health Services, Calgary
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-06
- **Final completion:** 2021-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788084, "Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02788084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*